{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:38:15Z","timestamp":1790959095548,"version":"4.1.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Agricultural and Social Development Science and Technology Project of Yinzhou District, Ningbo, China","award":["2024AS033"],"award-info":[{"award-number":["2024AS033"]}]},{"name":"The Science and Technology Development Project of Shanghai University of Traditional Chinese Medicine","award":["24KFL091"],"award-info":[{"award-number":["24KFL091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02238-1","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:17:47Z","timestamp":1775801867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["B cell-driven immune remodeling in inflammatory bowel disease: links to pathogenesis and therapeutic failure"],"prefix":"10.1007","volume":"75","author":[{"given":"Guomin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiemin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"issue":"10432","key":"2238_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"23","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S. Crohn\u2019s disease. Lancet Mar. 2024;23(10432):1177\u201391.","journal-title":"Lancet Mar"},{"issue":"10401","key":"2238_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"12","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet Aug. 2023;12(10401):571\u201384.","journal-title":"Lancet Aug"},{"issue":"10","key":"2238_CR3","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1136\/gutjnl-2024-332489","volume":"9","author":"S Honap","year":"2024","unstructured":"Honap S, Jairath V, Sands BE, Dulai PS, Danese S, Peyrin-Biroulet L. Acute severe ulcerative colitis trials: the past, the present and the future. Gut Sep. 2024;9(10):1763\u201373.","journal-title":"Gut Sep"},{"issue":"3","key":"2238_CR4","doi-asserted-by":"publisher","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","volume":"28","author":"R Wang","year":"2023","unstructured":"Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open Mar. 2023;28(3):e065186.","journal-title":"BMJ Open Mar"},{"issue":"2","key":"2238_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.gastro.2024.02.026","volume":"167","author":"M Khrom","year":"2024","unstructured":"Khrom M, Long M, Dube S, et al. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease. Gastroenterology Jul. 2024;167(2):315\u201332.","journal-title":"Gastroenterology Jul"},{"issue":"4","key":"2238_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G Rogler","year":"2021","unstructured":"Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology Oct. 2021;161(4):1118\u201332.","journal-title":"Gastroenterology Oct"},{"issue":"11","key":"2238_CR7","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/ecco-jcc\/jjae078","volume":"4","author":"AK Thomann","year":"2024","unstructured":"Thomann AK, Schmitgen MM, Stephan JC, et al. Associations Between Brain Morphology, Inflammatory Markers, and Symptoms of Fatigue, Depression, or Anxiety in Active and Remitted Crohn\u2019s Disease. J Crohns Colitis Nov. 2024;4(11):1767\u201379.","journal-title":"J Crohns Colitis Nov"},{"issue":"5","key":"2238_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","volume":"6","author":"B Barberio","year":"2021","unstructured":"Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol May. 2021;6(5):359\u201370.","journal-title":"Lancet Gastroenterol Hepatol May"},{"issue":"9","key":"2238_CR9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.14740\/jocmr4593","volume":"13","author":"FS Fousekis","year":"2021","unstructured":"Fousekis FS, Katsanos AH, Kourtis G, et al. Inflammatory Bowel Disease and Patients With Mental Disorders: What Do We Know? J Clin Med Res Sep. 2021;13(9):466\u201373.","journal-title":"J Clin Med Res Sep"},{"issue":"3","key":"2238_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah SC, Itzkowitz SH. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology Mar. 2022;162(3):715\u2013e7303.","journal-title":"Gastroenterology Mar"},{"issue":"9","key":"2238_CR11","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/ph16091272","volume":"16","author":"M Imbrizi","year":"2023","unstructured":"Imbrizi M, Magro F, Coy CSR. Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years. Pharmaceuticals (Basel). 2023;16(9):1272.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2238_CR12","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1186\/s12889-023-17431-8","volume":"14","author":"JL Zhou","year":"2023","unstructured":"Zhou JL, Bao JC, Liao XY, et al. Trends and projections of inflammatory bowel disease at the global, regional and national levels, 1990\u20132050: a bayesian age-period-cohort modeling study. BMC Public Health Dec. 2023;14(1):2507.","journal-title":"BMC Public Health Dec"},{"issue":"3","key":"2238_CR13","doi-asserted-by":"publisher","first-page":"e361","DOI":"10.1016\/j.cgh.2021.03.034","volume":"20","author":"W Ahmed","year":"2022","unstructured":"Ahmed W, Galati J, Kumar A, et al. Dual Biologic or Small Molecule Therapy for Treatment of Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol Mar. 2022;20(3):e361\u201379.","journal-title":"Clin Gastroenterol Hepatol Mar"},{"issue":"12","key":"2238_CR14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/17474124.2018.1545574","volume":"12","author":"SM Quezada","year":"2018","unstructured":"Quezada SM, McLean LP, Cross RK. Adverse events in IBD therapy: the 2018 update. Expert Rev Gastroenterol Hepatol Dec. 2018;12(12):1183\u201391.","journal-title":"Expert Rev Gastroenterol Hepatol Dec"},{"issue":"1","key":"2238_CR15","doi-asserted-by":"publisher","first-page":"otac002","DOI":"10.1093\/crocol\/otac002","volume":"4","author":"QA Alayo","year":"2022","unstructured":"Alayo QA, Fenster M, Altayar O, et al. Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease. Crohns Colitis 360 Jan. 2022;4(1):otac002.","journal-title":"Crohns Colitis 360 Jan"},{"issue":"8","key":"2238_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","volume":"24","author":"MF Neurath","year":"2024","unstructured":"Neurath MF. Strategies for targeting cytokines in inflammatory bowel disease. Nat Rev Immunol Aug. 2024;24(8):559\u201376.","journal-title":"Nat Rev Immunol Aug"},{"issue":"5","key":"2238_CR17","doi-asserted-by":"publisher","first-page":"jjaf052","DOI":"10.1093\/ecco-jcc\/jjaf052","volume":"8","author":"B Bokemeyer","year":"2025","unstructured":"Bokemeyer B, Plachta-Danielzik S, Gilman E, et al. Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study. J Crohns Colitis May. 2025;8(5):jjaf052.","journal-title":"J Crohns Colitis May"},{"issue":"Suppl 1","key":"2238_CR18","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1093\/jcag\/gwy055","volume":"2","author":"ME Kuenzig","year":"2019","unstructured":"Kuenzig ME, Benchimol EI, Lee L, et al. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization. J Can Assoc Gastroenterol Feb. 2019;2(Suppl 1):S17\u201333.","journal-title":"J Can Assoc Gastroenterol Feb"},{"issue":"3","key":"2238_CR19","first-page":"760","volume":"104","author":"JP Gisbert","year":"2009","unstructured":"Gisbert JP, Pan\u00e9s J. Loss of response and requirement of infliximab dose intensification in Crohn\u2019s disease: a review. Am J Gastroenterol Mar. 2009;104(3):760\u20137.","journal-title":"Am J Gastroenterol Mar"},{"key":"2238_CR20","first-page":"359","volume":"7","author":"I Guerra","year":"2014","unstructured":"Guerra I, Bermejo F. Management of inflammatory bowel disease in poor responders to infliximab. Clin Exp Gastroenterol. 2014;7:359\u201367.","journal-title":"Clin Exp Gastroenterol"},{"issue":"10","key":"2238_CR21","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.14309\/ajg.0000000000001396","volume":"1","author":"AS Cheifetz","year":"2021","unstructured":"Cheifetz AS, Abreu MT, Afif W, et al. A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease. Am J Gastroenterol. Oct 2021;1(10):2014\u201325.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2238_CR22","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.cgh.2024.01.026","volume":"22","author":"R Atreya","year":"2024","unstructured":"Atreya R, Neurath MF. Biomarkers for Personalizing IBD Therapy: The Quest Continues. Clin Gastroenterol Hepatol Jul. 2024;22(7):1353\u201364.","journal-title":"Clin Gastroenterol Hepatol Jul"},{"issue":"1","key":"2238_CR23","first-page":"9","volume":"10","author":"MF Neurath","year":"2024","unstructured":"Neurath MF, Sands BE, Rieder F. Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet? Gut. Dec. 2024;10(1):9\u201314.","journal-title":"Dec"},{"key":"2238_CR24","doi-asserted-by":"publisher","first-page":"101806","DOI":"10.1016\/j.smim.2023.101806","volume":"69","author":"O Pabst","year":"2023","unstructured":"Pabst O, Nowosad CR. B cells and the intestinal microbiome in time, space and place. Seminars immunology Sep. 2023;69:101806.","journal-title":"Seminars immunology Sep"},{"issue":"1","key":"2238_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/imr.13424","volume":"328","author":"PJ Gleeson","year":"2024","unstructured":"Gleeson PJ, Camara NOS, Launay P, Lehuen A, Monteiro RC. Immunoglobulin A Antibodies: From Protection to Harmful Roles. Immunological reviews Nov. 2024;328(1):171\u201391.","journal-title":"Immunological reviews Nov"},{"issue":"7882","key":"2238_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-03973-7","volume":"598","author":"T Rollenske","year":"2021","unstructured":"Rollenske T, Burkhalter S, Muerner L, et al. Parallelism of intestinal secretory IgA shapes functional microbial fitness. Nature Oct. 2021;598(7882):657\u201361.","journal-title":"Nature Oct"},{"key":"2238_CR27","first-page":"4822","volume-title":"IgA production requires B cell interaction with subepithelial dendritic cells in Peyer\u2019s patches","author":"A Reboldi","year":"2016","unstructured":"Reboldi A, Arnon TI, Rodda LB, Atakilit A, Sheppard D, Cyster JG. IgA production requires B cell interaction with subepithelial dendritic cells in Peyer\u2019s patches. Volume 352. New York, NY: Science; 2016. p. 4822-6287."},{"key":"2238_CR28","first-page":"107071","volume":"20","author":"FA Castillo","year":"2025","unstructured":"Castillo FA, Kern BC, Villablanca EJ. B cells in inflammatory bowel disease. Immunology letters Aug. 2025;20:277:107071.","journal-title":"Immunology letters Aug"},{"issue":"2","key":"2238_CR29","doi-asserted-by":"publisher","first-page":"e13139","DOI":"10.1111\/sji.13139","volume":"95","author":"A Fleming","year":"2022","unstructured":"Fleming A, Castro-Dopico T, Clatworthy MR. B cell class switching in intestinal immunity in health and disease. Scand J Immunol Feb. 2022;95(2):e13139.","journal-title":"Scand J Immunol Feb"},{"issue":"4","key":"2238_CR30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41591-022-01680-y","volume":"28","author":"M Uzzan","year":"2022","unstructured":"Uzzan M, Martin JC, Mesin L, et al. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. Nat Med Apr. 2022;28(4):766\u201379.","journal-title":"Nat Med Apr"},{"issue":"8","key":"2238_CR31","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1365-2036.2011.04605.x","volume":"33","author":"R Sura","year":"2011","unstructured":"Sura R, Colombel JF, Van Kruiningen HJ. Lymphatics, tertiary lymphoid organs and the granulomas of Crohn\u2019s disease: an immunohistochemical study. Aliment Pharmacol Ther Apr. 2011;33(8):930\u20139.","journal-title":"Aliment Pharmacol Ther Apr"},{"issue":"6","key":"2238_CR32","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","volume":"5","author":"JC Martin","year":"2019","unstructured":"Martin JC, Chang C, Boschetti G, et al. Single-Cell Analysis of Crohn\u2019s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell Sep. 2019;5(6):1493\u2013e150820.","journal-title":"Cell Sep"},{"issue":"3","key":"2238_CR33","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"25","author":"CS Smillie","year":"2019","unstructured":"Smillie CS, Biton M, Ordovas-Montanes J, et al. Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis. Cell Jul. 2019;25(3):714\u2013e73022.","journal-title":"Cell Jul"},{"issue":"1","key":"2238_CR34","first-page":"45","volume":"12","author":"M Kumric","year":"2021","unstructured":"Kumric M, Zivkovic PM, Ticinovic Kurir T, et al. Role of B-Cell Activating Factor (BAFF) in Inflammatory Bowel Disease. Diagnostics (Basel Switzerland). 2021;12(1):45.","journal-title":"Diagnostics (Basel Switzerland)"},{"issue":"suppl2","key":"2238_CR35","doi-asserted-by":"publisher","first-page":"S653","DOI":"10.1093\/ecco-jcc\/jjy060","volume":"22","author":"CA Lamb","year":"2018","unstructured":"Lamb CA, O\u2019Byrne S, Keir ME, Butcher EC. Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease. Journal Crohn\u2019s & colitis Aug. 2018;22(suppl2):S653\u201368.","journal-title":"Journal Crohn\u2019s & colitis Aug"},{"key":"2238_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","volume":"19","author":"RR Hardy","year":"2001","unstructured":"Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19:595\u2013621.","journal-title":"Annu Rev Immunol"},{"key":"2238_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-15-3532-1_1","volume":"1254","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu J, Burrows PD, Wang JY. B Cell Development and Maturation. Adv Exp Med Biol. 2020;1254:1\u201322.","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"2238_CR38","doi-asserted-by":"publisher","first-page":"e20778","DOI":"10.1016\/j.heliyon.2023.e20778","volume":"9","author":"J Diao","year":"2023","unstructured":"Diao J, Liu H, Cao H, Chen W. The dysfunction of Tfh cells promotes pediatric recurrent respiratory tract infections development by interfering humoral immune responses. Heliyon Oct. 2023;9(10):e20778.","journal-title":"Heliyon Oct"},{"issue":"7","key":"2238_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41577-024-00991-0","volume":"24","author":"DR Fooksman","year":"2024","unstructured":"Fooksman DR, Jing Z, Park R. New insights into the ontogeny, diversity, maturation and survival of long-lived plasma cells. Nature reviews Immunology Jul. 2024;24(7):461\u201370.","journal-title":"Nature reviews Immunology Jul"},{"issue":"4","key":"2238_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41575-023-00755-6","volume":"20","author":"J Spencer","year":"2023","unstructured":"Spencer J, Bemark M. Human intestinal B cells in inflammatory diseases. Nature reviews Gastroenterol & hepatology Apr. 2023;20(4):254\u201365.","journal-title":"Nature reviews Gastroenterol & hepatology Apr"},{"issue":"3","key":"2238_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.it.2024.01.006","volume":"45","author":"M Bemark","year":"2024","unstructured":"Bemark M, Pitcher MJ, Dionisi C, Spencer J. Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity. Trends Immunol Mar. 2024;45(3):211\u201323.","journal-title":"Trends Immunol Mar"},{"issue":"5","key":"2238_CR42","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/mi.2016.59","volume":"9","author":"J Spencer","year":"2016","unstructured":"Spencer J, Sollid LM. The human intestinal B-cell response. Mucosal Immunol Sep. 2016;9(5):1113\u201324.","journal-title":"Mucosal Immunol Sep"},{"issue":"4","key":"2238_CR43","doi-asserted-by":"publisher","first-page":"102777","DOI":"10.1016\/j.autrev.2021.102777","volume":"20","author":"M Zouali","year":"2021","unstructured":"Zouali M. B lymphocytes, the gastrointestinal tract and autoimmunity. Autoimmun Rev Apr. 2021;20(4):102777.","journal-title":"Autoimmun Rev Apr"},{"issue":"1","key":"2238_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41564-024-01873-w","volume":"10","author":"C Lei","year":"2025","unstructured":"Lei C, Luo C, Xu Z, et al. Bacterial and host fucosylation maintain IgA homeostasis to limit intestinal inflammation in mice. Nat Microbiol Jan. 2025;10(1):126\u201343.","journal-title":"Nat Microbiol Jan"},{"issue":"6","key":"2238_CR45","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/mi.2011.37","volume":"4","author":"FE Johansen","year":"2011","unstructured":"Johansen FE, Kaetzel CS. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol Nov. 2011;4(6):598\u2013602.","journal-title":"Mucosal Immunol Nov"},{"issue":"83","key":"2238_CR46","doi-asserted-by":"publisher","first-page":"eade2335","DOI":"10.1126\/sciimmunol.ade2335","volume":"26","author":"PE Conrey","year":"2023","unstructured":"Conrey PE, Denu L, O\u2019Boyle KC, et al. IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation. Sci Immunol May. 2023;26(83):eade2335.","journal-title":"Sci Immunol May"},{"issue":"1","key":"2238_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/sji.12499","volume":"85","author":"R Yazdani","year":"2017","unstructured":"Yazdani R, Azizi G, Abolhassani H, Aghamohammadi A. Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Scand J Immunol Jan. 2017;85(1):3\u201312.","journal-title":"Scand J Immunol Jan"},{"key":"2238_CR48","doi-asserted-by":"publisher","first-page":"100025","DOI":"10.1016\/j.jtauto.2019.100025","volume":"2","author":"S Swain","year":"2019","unstructured":"Swain S, Selmi C, Gershwin ME, Teuber SS. The clinical implications of selective IgA deficiency. J Transl Autoimmun Dec. 2019;2:100025.","journal-title":"J Transl Autoimmun Dec"},{"issue":"11\u201312","key":"2238_CR49","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2119\/molmed.2011.00195","volume":"17","author":"N Wang","year":"2011","unstructured":"Wang N, Shen N, Vyse TJ, et al. Selective IgA deficiency in autoimmune diseases. Mol Med. 2011;17(11\u201312):1383\u201396.","journal-title":"Mol Med"},{"issue":"12","key":"2238_CR50","doi-asserted-by":"publisher","first-page":"e20230079","DOI":"10.1084\/jem.20230079","volume":"221","author":"S Tejedor Vaquero","year":"2024","unstructured":"Tejedor Vaquero S, Neuman H, Comerma L, et al. Immunomolecular and reactivity landscapes of gut IgA subclasses in homeostasis and inflammatory bowel disease. J Exp Med. 2024;221(12):e20230079.","journal-title":"J Exp Med"},{"issue":"8","key":"2238_CR51","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.tim.2021.01.012","volume":"29","author":"M Ding","year":"2021","unstructured":"Ding M, Yang B, Ross RP, et al. Crosstalk between sIgA-Coated Bacteria in Infant Gut and Early-Life Health. Trends Microbiol Aug. 2021;29(8):725\u201335.","journal-title":"Trends Microbiol Aug"},{"issue":"5","key":"2238_CR52","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","volume":"28","author":"NW Palm","year":"2014","unstructured":"Palm NW, de Zoete MR, Cullen TW, et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell Aug. 2014;28(5):1000\u201310.","journal-title":"Cell Aug"},{"issue":"6330","key":"2238_CR53","first-page":"1211","volume":"17","author":"M Diard","year":"2017","unstructured":"Diard M, Bakkeren E, Cornuault JK, et al. Inflammation boosts bacteriophage transfer between Salmonella spp. Science Mar. 2017;17(6330):1211\u20135.","journal-title":"Science Mar"},{"issue":"6390","key":"2238_CR54","first-page":"795","volume":"18","author":"GP Donaldson","year":"2018","unstructured":"Donaldson GP, Ladinsky MS, Yu KB, et al. Gut microbiota utilize immunoglobulin A for mucosal colonization. Science May. 2018;18(6390):795\u2013800.","journal-title":"Science May"},{"issue":"6","key":"2238_CR55","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.immuni.2008.05.001","volume":"28","author":"A Cerutti","year":"2008","unstructured":"Cerutti A, Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity Jun. 2008;28(6):740\u201350.","journal-title":"Immunity Jun"},{"issue":"3","key":"2238_CR56","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","volume":"24","author":"FB Vincent","year":"2013","unstructured":"Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F. The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity. Cytokine Growth Factor Rev. 2013;24(3):203\u201315.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"2238_CR57","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41577-021-00506-1","volume":"21","author":"KE Huus","year":"2021","unstructured":"Huus KE, Petersen C, Finlay BB. Diversity and dynamism of IgA-microbiota interactions. Nat Rev Immunol Aug. 2021;21(8):514\u201325.","journal-title":"Nat Rev Immunol Aug"},{"issue":"7754","key":"2238_CR58","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-019-1125-3","volume":"569","author":"D Esterh\u00e1zy","year":"2019","unstructured":"Esterh\u00e1zy D, Canesso MCC, Mesin L, et al. Compartmentalized gut lymph node drainage dictates adaptive immune responses. Nature May. 2019;569(7754):126\u201330.","journal-title":"Nature May"},{"issue":"10","key":"2238_CR59","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.chom.2024.08.010","volume":"9","author":"Q Gu","year":"2024","unstructured":"Gu Q, Draheim M, Planchais C, et al. Intestinal newborn regulatory B cell antibodies modulate microbiota communities. Cell Host Microbe Oct. 2024;9(10):1787\u2013e18049.","journal-title":"Cell Host Microbe Oct"},{"key":"2238_CR60","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-981-15-3532-1_8","volume":"1254","author":"L Wang","year":"2020","unstructured":"Wang L, Fu Y, Chu Y, Regulatory B, Cells. Adv Exp Med Biol. 2020;1254:87\u2013103.","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"2238_CR61","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.cell.2019.07.047","volume":"22","author":"M Nagai","year":"2019","unstructured":"Nagai M, Noguchi R, Takahashi D, et al. Fasting-Refeeding Impacts Immune Cell Dynamics and Mucosal Immune Responses. Cell Aug. 2019;22(5):1072\u2013e108714.","journal-title":"Cell Aug"},{"issue":"2","key":"2238_CR62","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jaci.2018.12.991","volume":"143","author":"MC Berin","year":"2019","unstructured":"Berin MC. Mechanisms that define transient versus persistent food allergy. J Allergy Clin Immunol Feb. 2019;143(2):453\u20137.","journal-title":"J Allergy Clin Immunol Feb"},{"key":"2238_CR63","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3389\/fimmu.2020.00196","volume":"11","author":"H Michael","year":"2020","unstructured":"Michael H, Langel SN, Miyazaki A, et al. Malnutrition Decreases Antibody Secreting Cell Numbers Induced by an Oral Attenuated Human Rotavirus Vaccine in a Human Infant Fecal Microbiota Transplanted Gnotobiotic Pig Model. Front Immunol. 2020;11:196.","journal-title":"Front Immunol"},{"issue":"2","key":"2238_CR64","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41423-022-00944-4","volume":"20","author":"A Jordan-Paiz","year":"2023","unstructured":"Jordan-Paiz A, Martrus G, Steinert FL, et al. CXCR5(+)PD-1(++) CD4(+) T cells colonize infant intestines early in life and promote B cell maturation. Cell Mol Immunol Feb. 2023;20(2):201\u201313.","journal-title":"Cell Mol Immunol Feb"},{"issue":"46","key":"2238_CR65","doi-asserted-by":"publisher","first-page":"eaax0062","DOI":"10.1126\/sciimmunol.aax0062","volume":"5","author":"B Koscs\u00f3","year":"2020","unstructured":"Koscs\u00f3 B, Kurapati S, Rodrigues RR, et al. Gut-resident CX3CR1(hi) macrophages induce tertiary lymphoid structures and IgA response in situ. Sci Immunol. 2020;5(46):eaax0062.","journal-title":"Sci Immunol"},{"issue":"6","key":"2238_CR66","doi-asserted-by":"publisher","first-page":"a022236","DOI":"10.1101\/cshperspect.a022236","volume":"1","author":"S Sanjabi","year":"2017","unstructured":"Sanjabi S, Oh SA, Li MO. Regulation of the Immune Response by TGF-\u03b2: From Conception to Autoimmunity and Infection. Cold Spring Harb Perspect Biol Jun. 2017;1(6):a022236.","journal-title":"Cold Spring Harb Perspect Biol Jun"},{"issue":"5","key":"2238_CR67","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","volume":"21","author":"ST Crotty","year":"2019","unstructured":"Crotty ST, Follicular Helper. Cell Biology: A Decade of Discovery and Diseases. Immunity May. 2019;21(5):1132\u201348.","journal-title":"Immunity May"},{"issue":"7492","key":"2238_CR68","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"20","author":"P Shen","year":"2014","unstructured":"Shen P, Roch T, Lampropoulou V, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature Mar. 2014;20(7492):366\u201370.","journal-title":"Nature Mar"},{"issue":"7","key":"2238_CR69","doi-asserted-by":"publisher","first-page":"e3715","DOI":"10.1002\/jgm.3715","volume":"26","author":"ZY Li","year":"2024","unstructured":"Li ZY, Sun YH, Qian H, Wang HY, Wang YJ, Miao J. Single-cell analysis of Crohn\u2019s disease: Unveiling heterogeneity and evaluating ustekinumab outcomes. J Gene Med Jul. 2024;26(7):e3715.","journal-title":"J Gene Med Jul"},{"issue":"4","key":"2238_CR70","doi-asserted-by":"publisher","first-page":"nwaf009","DOI":"10.1093\/nsr\/nwaf009","volume":"12","author":"D Chen","year":"2025","unstructured":"Chen D, Xu S, Li S, et al. The multi-organ landscape of B cells highlights dysregulated memory B cell responses in Crohn\u2019s disease. Natl Sci Rev Apr. 2025;12(4):nwaf009.","journal-title":"Natl Sci Rev Apr"},{"key":"2238_CR71","doi-asserted-by":"publisher","first-page":"1260266","DOI":"10.3389\/fimmu.2023.1260266","volume":"14","author":"R Zogorean","year":"2023","unstructured":"Zogorean R, Wirtz S. The yin and yang of B cells in a constant state of battle: intestinal inflammation and inflammatory bowel disease. Front Immunol. 2023;14:1260266.","journal-title":"Front Immunol"},{"issue":"4","key":"2238_CR72","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/1756283X16638833","volume":"9","author":"U Kopylov","year":"2016","unstructured":"Kopylov U, Seidman E. Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease. Therap Adv Gastroenterol Jul. 2016;9(4):513\u201326.","journal-title":"Therap Adv Gastroenterol Jul"},{"issue":"4","key":"2238_CR73","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.immuni.2019.02.006","volume":"16","author":"T Castro-Dopico","year":"2019","unstructured":"Castro-Dopico T, Dennison TW, Ferdinand JR, et al. Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis. Immunity Apr. 2019;16(4):1099\u2013e111410.","journal-title":"Immunity Apr"},{"issue":"1","key":"2238_CR74","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.immuni.2007.12.004","volume":"28","author":"MJ Shlomchik","year":"2008","unstructured":"Shlomchik MJ. Sites and stages of autoreactive B cell activation and regulation. Immunity Jan. 2008;28(1):18\u201328.","journal-title":"Immunity Jan"},{"issue":"12","key":"2238_CR75","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.immuni.2022.11.002","volume":"13","author":"A Frede","year":"2022","unstructured":"Frede A, Czarnewski P, Monasterio G, et al. B cell expansion hinders the stroma-epithelium regenerative cross talk during mucosal healing. Immunity Dec. 2022;13(12):2336\u2013e235112.","journal-title":"Immunity Dec"},{"issue":"1","key":"2238_CR76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mucimm.2023.10.005","volume":"17","author":"I Gadjalova","year":"2024","unstructured":"Gadjalova I, Heinze JM, Goess MC, et al. B cell-mediated CD4 T-cell costimulation via CD86 exacerbates pro-inflammatory cytokine production during autoimmune intestinal inflammation. Mucosal Immunol Feb. 2024;17(1):67\u201380.","journal-title":"Mucosal Immunol Feb"},{"key":"2238_CR77","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.coph.2020.10.002","volume":"55","author":"T Castro-Dopico","year":"2020","unstructured":"Castro-Dopico T, Colombel JF, Mehandru S. Targeting B cells for inflammatory bowel disease treatment: back to the future. Curr Opin Pharmacol Dec. 2020;55:90\u20138.","journal-title":"Curr Opin Pharmacol Dec"},{"issue":"6","key":"2238_CR78","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1084\/jem.20071572","volume":"9","author":"Y Shimomura","year":"2008","unstructured":"Shimomura Y, Ogawa A, Kawada M, et al. A unique B2 B cell subset in the intestine. J Exp Med Jun. 2008;9(6):1343\u201355.","journal-title":"J Exp Med Jun"},{"issue":"3","key":"2238_CR79","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1172\/JCI200420855","volume":"114","author":"TS Olson","year":"2004","unstructured":"Olson TS, Bamias G, Naganuma M, et al. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Invest Aug. 2004;114(3):389\u201398.","journal-title":"J Clin Invest Aug"},{"issue":"7","key":"2238_CR80","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41590-022-01230-1","volume":"23","author":"GE Phad","year":"2022","unstructured":"Phad GE, Pinto D, Foglierini M, et al. Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts. Nat Immunol Jul. 2022;23(7):1076\u201385.","journal-title":"Nat Immunol Jul"},{"issue":"3","key":"2238_CR81","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20111696","volume":"12","author":"JJ Taylor","year":"2012","unstructured":"Taylor JJ, Pape KA, Jenkins MK. A germinal center-independent pathway generates unswitched memory B cells early in the primary response. J Exp Med Mar. 2012;12(3):597\u2013606.","journal-title":"J Exp Med Mar"},{"issue":"6","key":"2238_CR82","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/mi.2011.36","volume":"4","author":"JE Bakema","year":"2011","unstructured":"Bakema JE, van Egmond M. The human immunoglobulin A Fc receptor Fc\u03b1RI: a multifaceted regulator of mucosal immunity. Mucosal Immunol Nov. 2011;4(6):612\u201324.","journal-title":"Mucosal Immunol Nov"},{"issue":"12","key":"2238_CR83","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00262-024-03824-0","volume":"3","author":"C Chan","year":"2024","unstructured":"Chan C, Cabanes NC, Jansen JHM, et al. The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy. Cancer Immunol Immunother Oct. 2024;3(12):238.","journal-title":"Cancer Immunol Immunother Oct"},{"key":"2238_CR84","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fimmu.2019.00504","volume":"10","author":"DV Rizk","year":"2019","unstructured":"Rizk DV, Maillard N, Julian BA, et al. The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy. Front Immunol. 2019;10:504.","journal-title":"Front Immunol"},{"issue":"3","key":"2238_CR85","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/biolre\/ioad068","volume":"12","author":"C Lu","year":"2023","unstructured":"Lu C, Wu Z, Gao H, et al. Sperm induce macrophage extracellular trap formation via phagocytosis-dependent mechanism. Biol Reprod Sep. 2023;12(3):319\u201329.","journal-title":"Biol Reprod Sep"},{"key":"2238_CR86","doi-asserted-by":"publisher","first-page":"105256","DOI":"10.1016\/j.ebiom.2024.105256","volume":"106","author":"Y Kinashi","year":"2024","unstructured":"Kinashi Y, Tanaka K, Kimura S, et al. Intestinal epithelium dysfunctions cause IgA deposition in the kidney glomeruli of intestine-specific Ap1m2-deficient mice. EBioMedicine Aug. 2024;106:105256.","journal-title":"EBioMedicine Aug"},{"issue":"10","key":"2238_CR87","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/biom14101210","volume":"26","author":"PGE Kennedy","year":"2024","unstructured":"Kennedy PGE, Fultz M, Phares J, Yu X. Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis. Biomolecules Sep. 2024;26(10):1210.","journal-title":"Biomolecules Sep"},{"key":"2238_CR88","doi-asserted-by":"publisher","first-page":"107071","DOI":"10.1016\/j.imlet.2025.107071","volume":"277","author":"FA Castillo","year":"2026","unstructured":"Castillo FA, Kern BC, Villablanca EJ. B cells in inflammatory bowel disease. Immunol Lett Feb. 2026;277:107071.","journal-title":"Immunol Lett Feb"},{"issue":"7","key":"2238_CR89","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41588-025-02225-y","volume":"57","author":"L Kong","year":"2025","unstructured":"Kong L, Subramanian S, Segerstolpe \u00c5, et al. Single-cell and spatial transcriptomics of stricturing Crohn\u2019s disease highlights a fibrosis-associated network. Nat Genet Jul. 2025;57(7):1742\u201353.","journal-title":"Nat Genet Jul"},{"issue":"7","key":"2238_CR90","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1053\/j.gastro.2021.02.019","volume":"160","author":"T Kuwada","year":"2021","unstructured":"Kuwada T, Shiokawa M, Kodama Y, et al. Identification of an Anti-Integrin \u03b1v\u03b26 Autoantibody in Patients With Ulcerative Colitis. Gastroenterology Jun. 2021;160(7):2383\u2013e239421.","journal-title":"Gastroenterology Jun"},{"issue":"2","key":"2238_CR91","doi-asserted-by":"publisher","first-page":"103720","DOI":"10.1016\/j.autrev.2024.103720","volume":"31","author":"S Bencardino","year":"2025","unstructured":"Bencardino S, Matichecchia CS, Fanizza J, et al. IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease. Autoimmun Rev Jan. 2025;31(2):103720.","journal-title":"Autoimmun Rev Jan"},{"issue":"9","key":"2238_CR92","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1084\/jem.20111453","volume":"27","author":"M Coccia","year":"2012","unstructured":"Coccia M, Harrison OJ, Schiering C, et al. IL-1\u03b2 mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med Aug. 2012;27(9):1595\u2013609.","journal-title":"J Exp Med Aug"},{"issue":"5","key":"2238_CR93","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41590-025-02125-7","volume":"26","author":"T Fan","year":"2025","unstructured":"Fan T, Tai C, Sleiman KC, et al. Aberrant T follicular helper cells generated by T(H)17 cell plasticity in the gut promote extraintestinal autoimmunity. Nat Immunol May. 2025;26(5):790\u2013804.","journal-title":"Nat Immunol May"},{"issue":"32","key":"2238_CR94","doi-asserted-by":"publisher","first-page":"14292","DOI":"10.1073\/pnas.1009234107","volume":"10","author":"M Mitsdoerffer","year":"2010","unstructured":"Mitsdoerffer M, Lee Y, J\u00e4ger A, et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A Aug. 2010;10(32):14292\u20137.","journal-title":"Proc Natl Acad Sci U S A Aug"},{"issue":"3","key":"2238_CR95","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3960\/jslrt.24040","volume":"64","author":"T Kitaoka","year":"2024","unstructured":"Kitaoka T, Ohe R, Kabasawa T, et al. Activation of fibroblasts by plasma cells via PDGF\/PDGFR signaling in IgG4-related sialadenitis. J Clin Exp Hematop. 2024;64(3):223\u201331.","journal-title":"J Clin Exp Hematop"},{"issue":"4","key":"2238_CR96","first-page":"423","volume":"36","author":"RC Chase","year":"2023","unstructured":"Chase RC, Tamim H, Sheikh WGE, et al. Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease. Ann Gastroenterol Jul-Aug. 2023;36(4):423\u20139.","journal-title":"Ann Gastroenterol Jul-Aug"},{"issue":"9","key":"2238_CR97","first-page":"4537","volume":"11","author":"X Chen","year":"2018","unstructured":"Chen X, Sun W, Lin R, Huang Z, Chen W. IgG4\u2009+\u2009plasma cell infiltration is correlated with the development of inflammatory bowel disease and can be regulated by TLR-4. Int J Clin Exp Pathol. 2018;11(9):4537\u201344.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"2238_CR98","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41423-024-01233-y","volume":"22","author":"X Meng","year":"2025","unstructured":"Meng X, Asadi-Asadabad S, Cao S, et al. Metabolic rewiring controlled by HIF-1\u03b1 tunes IgA-producing B-cell differentiation and intestinal inflammation. Cell Mol Immunol Jan. 2025;22(1):54\u201367.","journal-title":"Cell Mol Immunol Jan"},{"issue":"4","key":"2238_CR99","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","volume":"6","author":"AF McGettrick","year":"2020","unstructured":"McGettrick AF, O\u2019Neill LAJ. The Role of HIF in Immunity and Inflammation. Cell Metab Oct. 2020;6(4):524\u201336.","journal-title":"Cell Metab Oct"},{"issue":"10","key":"2238_CR100","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1089\/dna.2016.3304","volume":"35","author":"Z Wang","year":"2016","unstructured":"Wang Z, Wang Z, Wang J, Diao Y, Qian X, Zhu N, T-bet-Expressing B. Cells Are Positively Associated with Crohn\u2019s Disease Activity and Support Th1 Inflammation. DNA Cell Biol Oct. 2016;35(10):628\u201335.","journal-title":"DNA Cell Biol Oct"},{"issue":"21","key":"2238_CR101","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.devcel.2024.07.017","volume":"4","author":"A Bond","year":"2024","unstructured":"Bond A, Fiaz S, Rollins K, et al. Prior Fc receptor activation primes macrophages for increased sensitivity to IgG via long-term and short-term mechanisms. Dev Cell Nov. 2024;4(21):2882\u2013e28967.","journal-title":"Dev Cell Nov"},{"key":"2238_CR102","doi-asserted-by":"publisher","first-page":"627535","DOI":"10.3389\/fimmu.2021.627535","volume":"12","author":"MM Prins","year":"2021","unstructured":"Prins MM, Verstockt B, Ferrante M, Vermeire S, Wildenberg ME, Koelink PJ. Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fc\u03b3-Receptor Signaling Pathways. Front Immunol. 2021;12:627535.","journal-title":"Front Immunol"},{"issue":"4","key":"2238_CR103","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","volume":"16","author":"M Friedrich","year":"2019","unstructured":"Friedrich M, Pohin M, Powrie F. Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease. Immunity Apr. 2019;16(4):992\u20131006.","journal-title":"Immunity Apr"},{"issue":"8","key":"2238_CR104","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cmet.2022.07.002","volume":"2","author":"T H\u00e4ggl\u00f6f","year":"2022","unstructured":"H\u00e4ggl\u00f6f T, Vanz C, Kumagai A, et al. T-bet(+) B cells accumulate in adipose tissue and exacerbate metabolic disorder during obesity. Cell Metab Aug. 2022;2(8):1121\u2013e11366.","journal-title":"Cell Metab Aug"},{"key":"2238_CR105","doi-asserted-by":"publisher","first-page":"1352946","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, Zhao F, Cheng H, Su M, Wang Y. Macrophage polarization: an important role in inflammatory diseases. Front Immunol. 2024;15:1352946.","journal-title":"Front Immunol"},{"issue":"12","key":"2238_CR106","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.it.2016.10.003","volume":"37","author":"BA Heesters","year":"2016","unstructured":"Heesters BA, van der Poel CE, Das A, Carroll MC. Antigen Presentation to B Cells. Trends Immunol Dec. 2016;37(12):844\u201354.","journal-title":"Trends Immunol Dec"},{"key":"2238_CR107","doi-asserted-by":"publisher","first-page":"1055914","DOI":"10.3389\/fimmu.2022.1055914","volume":"13","author":"L Chen","year":"2022","unstructured":"Chen L, Ruan G, Cheng Y, Yi A, Chen D, Wei Y. The role of Th17 cells in inflammatory bowel disease and the research progress. Front Immunol. 2022;13:1055914.","journal-title":"Front Immunol"},{"issue":"5","key":"2238_CR108","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/ibd\/izac199","volume":"2","author":"H Cao","year":"2023","unstructured":"Cao H, Diao J, Liu H, et al. The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases. Inflamm Bowel Dis May. 2023;2(5):818\u201329.","journal-title":"Inflamm Bowel Dis May"},{"issue":"3","key":"2238_CR109","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","volume":"20","author":"DSW Lee","year":"2021","unstructured":"Lee DSW, Rojas OL, Gommerman JL. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat Rev Drug Discov Mar. 2021;20(3):179\u201399.","journal-title":"Nat Rev Drug Discov Mar"},{"issue":"2","key":"2238_CR110","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/1753425913485475","volume":"20","author":"J Junginger","year":"2014","unstructured":"Junginger J, Lemensieck F, Moore PF, Schwittlick U, Nolte I, Hewicker-Trautwein M. Canine gut dendritic cells in the steady state and in inflammatory bowel disease. Innate Immun Feb. 2014;20(2):145\u201360.","journal-title":"Innate Immun Feb"},{"key":"2238_CR111","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.ai.2019.08.008","volume":"144","author":"Q Huang","year":"2019","unstructured":"Huang Q, Xu L, Ye L. T cell immune response within B-cell follicles. Adv Immunol. 2019;144:155\u201371.","journal-title":"Adv Immunol"},{"key":"2238_CR112","doi-asserted-by":"publisher","first-page":"9621738","DOI":"10.1155\/2021\/9621738","volume":"2021","author":"L Sun","year":"2021","unstructured":"Sun L, Kong R, Li H, Wang D. The Role of T Follicular Helper Cells and Interleukin-21 in the Pathogenesis of Inflammatory Bowel Disease. Gastroenterol Res Pract. 2021;2021:9621738.","journal-title":"Gastroenterol Res Pract"},{"issue":"3","key":"2238_CR113","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1167\/iovs.66.3.8","volume":"3","author":"Z Li","year":"2025","unstructured":"Li Z, Liu X, Li Z, et al. STING Deficiency Promotes Th17-Like Tfh to Aggravate the Experimental Autoimmune Uveitis. Invest Ophthalmol Vis Sci Mar. 2025;3(3):8.","journal-title":"Invest Ophthalmol Vis Sci Mar"},{"issue":"14","key":"2238_CR114","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1182\/blood-2009-10-250126","volume":"8","author":"S Merluzzi","year":"2010","unstructured":"Merluzzi S, Frossi B, Gri G, Parusso S, Tripodo C, Pucillo C. Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells. Blood Apr. 2010;8(14):2810\u20137.","journal-title":"Blood Apr"},{"issue":"2","key":"2238_CR115","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/eji.202048668","volume":"51","author":"V Valeri","year":"2021","unstructured":"Valeri V, Tonon S, Vibhushan S, et al. Mast cells crosstalk with B cells in the gut and sustain IgA response in the inflamed intestine. Eur J Immunol Feb. 2021;51(2):445\u201358.","journal-title":"Eur J Immunol Feb"},{"key":"2238_CR116","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.coph.2015.11.005","volume":"25","author":"G Boeckxstaens","year":"2015","unstructured":"Boeckxstaens G. Mast cells and inflammatory bowel disease. Curr Opin Pharmacol Dec. 2015;25:45\u20139.","journal-title":"Curr Opin Pharmacol Dec"},{"issue":"12","key":"2238_CR117","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1016\/j.immuni.2022.11.011","volume":"13","author":"EK Grasset","year":"2022","unstructured":"Grasset EK, Alenghat T. Good intentions gone wrong: The B cell block to epithelial repair. Immunity Dec. 2022;13(12):2222\u20134.","journal-title":"Immunity Dec"},{"issue":"6","key":"2238_CR118","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/ecco-jcc\/jjad203","volume":"3","author":"C Kapizioni","year":"2024","unstructured":"Kapizioni C, Desoki R, Lam D, et al. Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource. J Crohns Colitis Jun. 2024;3(6):790\u2013800.","journal-title":"J Crohns Colitis Jun"},{"issue":"1","key":"2238_CR119","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12967-024-05058-1","volume":"16","author":"M Kumar","year":"2024","unstructured":"Kumar M, Murugesan S, Ibrahim N, Elawad M, Al Khodor S. Predictive biomarkers for anti-TNF alpha therapy in IBD patients. J Transl Med Mar. 2024;16(1):284.","journal-title":"J Transl Med Mar"},{"issue":"12","key":"2238_CR120","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11894-021-00829-y","volume":"16","author":"L Sattler","year":"2021","unstructured":"Sattler L, Hanauer SB, Malter L. Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12\/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine \/ 6-MP and Methotrexate). Curr Gastroenterol Rep Dec. 2021;16(12):30.","journal-title":"Curr Gastroenterol Rep Dec"},{"issue":"3","key":"2238_CR121","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/14712598.2024.2316180","volume":"24","author":"A Tursi","year":"2024","unstructured":"Tursi A, Mocci G, Del Gaudio A, Papa A. Clinical use of biologics for Crohn\u2019s disease in adults: lessons learned from real-world studies. Expert Opin Biol Ther Mar. 2024;24(3):171\u201389.","journal-title":"Expert Opin Biol Ther Mar"},{"issue":"12","key":"2238_CR122","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1097\/MIB.0000000000000554","volume":"21","author":"Z Li","year":"2015","unstructured":"Li Z, Vermeire S, Bullens D, et al. Anti-Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases. Inflamm Bowel Dis Dec. 2015;21(12):2787\u201396.","journal-title":"Inflamm Bowel Dis Dec"},{"issue":"6","key":"2238_CR123","doi-asserted-by":"publisher","first-page":"e202403055","DOI":"10.26508\/lsa.202403055","volume":"8","author":"A Schnell","year":"2025","unstructured":"Schnell A, Schwarz B, Schmidt H, et al. Adenosine-generating CD39(+) plasmablasts predispose to successful infliximab therapy in pediatric IBD. Life Sci Alliance Jun. 2025;8(6):e202403055.","journal-title":"Life Sci Alliance Jun"},{"issue":"94","key":"2238_CR124","doi-asserted-by":"publisher","first-page":"eadg7549","DOI":"10.1126\/sciimmunol.adg7549","volume":"19","author":"P Canales-Herrerias","year":"2024","unstructured":"Canales-Herrerias P, Uzzan M, Seki A, et al. Gut-associated lymphoid tissue attrition associates with response to anti-\u03b14\u03b27 therapy in ulcerative colitis. Sci Immunol Apr. 2024;19(94):eadg7549.","journal-title":"Sci Immunol Apr"},{"issue":"1","key":"2238_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmgh.2020.07.005","volume":"11","author":"AM Globig","year":"2021","unstructured":"Globig AM, Sommer NP, Wild K, et al. Ustekinumab Inhibits T Follicular Helper Cell Differentiation in Patients With Crohn\u2019s Disease. Cell Mol Gastroenterol Hepatol. 2021;11(1):1\u201312.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"2238_CR126","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2019.08.009","volume":"157","author":"H Bar-Yoseph","year":"2019","unstructured":"Bar-Yoseph H, Pressman S, Blatt A, et al. Infliximab-Tumor Necrosis Factor Complexes Elicit Formation of Anti-Drug Antibodies. Gastroenterology Nov. 2019;157(5):1338\u2013e13518.","journal-title":"Gastroenterology Nov"},{"key":"2238_CR127","first-page":"1","volume":"25","author":"K Sharma","year":"2025","unstructured":"Sharma K, da Silva BC, Hanauer SB. The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease. Expert Rev Gastroenterol Hepatol Feb. 2025;25:1\u201316.","journal-title":"Expert Rev Gastroenterol Hepatol Feb"},{"issue":"1","key":"2238_CR128","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000541377","volume":"9","author":"M Farber","year":"2024","unstructured":"Farber M, Polman J, Kohn N, Chua V, Swaminath A, Sultan K. A Real-World Comparison of Drug Trough Levels between Patients Experiencing a Secondary Nonimmune Loss of Response and Those Maintaining a Response to Infliximab on Long-Term Maintenance Therapy for Inflammatory Bowel Disease. Inflamm Intest Dis Jan-Dec. 2024;9(1):252\u20139.","journal-title":"Inflamm Intest Dis Jan-Dec"},{"issue":"7","key":"2238_CR129","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/jgh.14584","volume":"34","author":"N Van den Berghe","year":"2019","unstructured":"Van den Berghe N, Verstockt B, Tops S, Ferrante M, Vermeire S, Gils A. Immunogenicity is not the driving force of treatment failure in vedolizumab-treated inflammatory bowel disease patients. J Gastroenterol Hepatol Jul. 2019;34(7):1175\u201381.","journal-title":"J Gastroenterol Hepatol Jul"},{"issue":"2","key":"2238_CR130","doi-asserted-by":"publisher","first-page":"418","DOI":"10.4049\/jimmunol.1601246","volume":"15","author":"C Arnoult","year":"2017","unstructured":"Arnoult C, Brachet G, Cadena Castaneda D, et al. Crucial Role for Immune Complexes but Not FcRn in Immunization against Anti-TNF-\u03b1 Antibodies after a Single Injection in Mice. J Immunol Jul. 2017;15(2):418\u201324.","journal-title":"J Immunol Jul"},{"issue":"1","key":"2238_CR131","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13577","volume":"1415","author":"M Uzzan","year":"2018","unstructured":"Uzzan M, Ko HM, Rosenstein AK, Pourmand K, Colombel JF, Mehandru S. Efficient long-term depletion of CD20(+) B cells by rituximab does not affect gut-resident plasma cells. Ann N Y Acad Sci Mar. 2018;1415(1):5\u201310.","journal-title":"Ann N Y Acad Sci Mar"},{"issue":"5","key":"2238_CR132","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/cells10051175","volume":"10","author":"CE den Geyer","year":"2021","unstructured":"Geyer CE, Mes L, Newling M, den Dunnen J, Hoepel W. Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins. Cells May. 2021;10(5):1175.","journal-title":"Cells May"},{"issue":"1","key":"2238_CR133","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s42003-024-07276-1","volume":"29","author":"M Holm","year":"2024","unstructured":"Holm M, Stepanauskait\u0117 L, B\u00e4ckstr\u00f6m A, et al. Spatial profiling of the mouse colonic immune landscape associated with colitis and sex. Commun Biol Nov. 2024;29(1):1595.","journal-title":"Commun Biol Nov"},{"issue":"8","key":"2238_CR134","doi-asserted-by":"publisher","first-page":"116039","DOI":"10.1016\/j.celrep.2025.116039","volume":"26","author":"D Richards","year":"2025","unstructured":"Richards D, Sohn K, Basavarajappa SC, et al. Immune signaling mediates stromal changes to support epithelial reprogramming in celiac duodenum. Cell Rep Aug. 2025;26(8):116039.","journal-title":"Cell Rep Aug"},{"issue":"5","key":"2238_CR135","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1172\/JCI121668","volume":"2","author":"L Belarif","year":"2019","unstructured":"Belarif L, Danger R, Kermarrec L, et al. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease. J Clin Invest Apr. 2019;2(5):1910\u201325.","journal-title":"J Clin Invest Apr"},{"key":"2238_CR136","doi-asserted-by":"publisher","first-page":"747324","DOI":"10.3389\/fimmu.2021.747324","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen D, Tang TX, Deng H, Yang XP, Tang ZH. Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis. Front Immunol. 2021;12:747324.","journal-title":"Front Immunol"},{"issue":"4","key":"2238_CR137","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41419-020-2470-8","volume":"24","author":"H Li","year":"2020","unstructured":"Li H, Feng C, Fan C, et al. Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis. Cell Death Dis Apr. 2020;24(4):271.","journal-title":"Cell Death Dis Apr"},{"issue":"5","key":"2238_CR138","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nm.4307","volume":"23","author":"NR West","year":"2017","unstructured":"West NR, Hegazy AN, Owens BMJ, et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med. 2017;23(5):579\u201389.","journal-title":"Nat Med"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02238-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02238-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02238-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:03:53Z","timestamp":1775804633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02238-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2238"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02238-1","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm that this manuscript has not been published by other journals. All authors have approved the manuscript and agree with its submission to this journal. The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"90"}}